Concepedia

Kendra S. Hendon

KS

Statistics

Publications

2

Citations

211

H-Index

2

Active since

2021

Affiliations

Akebia Therapeutics (United States)(Current)

Kendra S. Hendon is an author at Akebia Therapeutics (United States) specializing in nephrology, pharmacology, and medicine.

Publications per year

2021–2023

2

Publications

2

Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial

Joana Silva, A. L. J. Buckle, Kendra S. Hendon · The Lancet · 2023 · 187 citations · Full text

, , +13

PATENCY-2 trial of vonapanitase to promote radiocephalic fistula use for hemodialysis and secondary patency

Eric K. Peden, John F. Lucas, Barry J. Browne et al. · The Journal of Vascular Access · 2021 · 24 citations

, , +13

1–2 of 2